1. Atopic Dermatitis in US Adults: From Population to Health Care Utilization 
Jonathan I. Silverberg, MD, PhD, MPH, Joel M. Gelfand, MD, MSCE, David J. Margolis, MD, PhD, Mark Boguniewicz, MD, Luz Fonacier, MD, Mitchell H. Grayson, MD, Peck Y. Ong, MD, Zelma Chiesa Fuxench, MD, MSCE, Eric L. Simpson, MD, MCR 
The Journal of Allergy and Clinical Immunology: In Practice 
Volume 7, Issue 5, Pages e2 (May 2019)
DOI: /j.jaip
Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Figure 1
Weighted prevalence (95% CIs) of AD, AD diagnosis, severity, and utilization in US adults.
The Journal of Allergy and Clinical Immunology: In Practice 2019 7, e2DOI: ( /j.jaip )
Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3. Figure E1
Weighted prevalence (95% CIs) of AD, AD diagnosis, severity, and utilization in US adults using sensitivity analyses of UKWP criteria with an age of onset criterion of less than 2 years.
The Journal of Allergy and Clinical Immunology: In Practice 2019 7, e2DOI: ( /j.jaip )
Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4. Figure E2
Weighted prevalence (95% CIs) of AD, AD diagnosis, severity, and utilization in US adults using UKWP criteria with an age of onset criterion of less than 18 y and sensitivity analyses using different severity strata for POEM (mild = 0-7, moderate = 8-18, and severe = 9-28) and PO-SCORAD (mild = 0-27, moderate = 28-56, and severe = ).
The Journal of Allergy and Clinical Immunology: In Practice 2019 7, e2DOI: ( /j.jaip )
Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5. Figure E3
Weighted prevalence (95% CIs) of AD, AD diagnosis, severity, and utilization in US adults using sensitivity analyses of UKWP criteria with an age of onset criterion of less than 2 y and sensitivity analyses using different severity strata for POEM (mild = 0-7, moderate = 8-18, and severe = 9-28) and PO-SCORAD (mild = 0-27, moderate = 28-56, and severe = ).
The Journal of Allergy and Clinical Immunology: In Practice 2019 7, e2DOI: ( /j.jaip )
Copyright © 2019 American Academy of Allergy, Asthma & Immunology Terms and Conditions